Skip to main content
. 2021 Sep 22;12:734927. doi: 10.3389/fneur.2021.734927

Figure 2.

Figure 2

Association of pre-stroke statin use with (A) symptomatic intracranial hemorrhage, (B) any intracranial hemorrhage, (C) 3-month mortality, (D) 3-month favorable functional outcome, and (E) 3-month functional independence.